HONG KONG, Aug. 10, 2026 /PRNewswire/ -- Per BIOHK2025 official briefing materials, a Swiss cell therapy biotech founder scans the bustling conference floor of BIOHK2025, shaking hands with Nobel ...

Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, ...

Michelle Ross, Stempoint Capital CIO, joins 'Closing Bell' to talk her perspective on the Biotech sector, companies she is ...

Yuling Luo rang the Nasdaq closing bell Friday having taken his first company public in a massively oversubscribed round. The Alamar Biosciences CEO’s IPO was one of two back-to-back blockbuster ...

Scientists at the Department of Energy's Oak Ridge National Laboratory have created a platform that pinpoints genetic ...

The CBO CEO relationship shapes biotech deal success. Discover insights from 19 industry leaders on board alignment and partnering.

The startup is the 12th drug company to bank at least $250 million in an IPO this year, nearly matching totals last seen ...

Armed with a $17 million series A in 2022 from the likes of Builders VC, Khosla Ventures and TechU Ventures, the company’s ...

A transatlantic partnership gives biotech startups lower-cost access to lab equipment while reducing waste and Scope 3 ...

Generate Biomedicines focuses on AI-enabled drug discovery.

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

The UC Santa Cruz Genomics Institute partnered with Santa Cruz Works to host a rooftop mixer in late October 2025 that fostered new connections among researchers, local entrepreneurs, investors, and ...